Improving mental health for vulnerable populations in New York City after COVID-19
REstoring Mental Health Through COmmUnity-based Psychological (RECOUP-NY)
This study is testing a new way to improve mental health for vulnerable communities in New York City affected by COVID-19 by providing community-based support to see if it helps with issues like depression and anxiety.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | George Washington University Academic / other |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT04913766 on ClinicalTrials.gov |
What this trial studies
This study aims to enhance the mental health of minority and vulnerable populations in New York City who have been disproportionately affected by the COVID-19 pandemic. It evaluates the effectiveness of community-based psychological services delivered by trained non-specialists to address issues such as depression, anxiety, and PTSD. The approach involves a cluster randomized control trial comparing standard services to the new intervention, focusing on improving mental health outcomes and public health behaviors related to COVID-19 mitigation. The study is part of a broader initiative to maximize the reach and effectiveness of mental health services in underserved communities.
Who should consider this trial
Good fit: Ideal candidates include individuals experiencing psychological distress with functional impairment, particularly from minority and underserved communities.
Not a fit: Patients with acute suicide risk or those without functional impairment may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly improve mental health outcomes and access to care for vulnerable populations affected by the pandemic.
How similar studies have performed: Other studies have shown success with community-based mental health interventions, indicating potential for positive outcomes in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Persons with Patient Health Questionnaire 4 scores equal to or above 3 * Functional impairment associated with psychological distress Exclusion Criteria: * Acute suicide risk * Patient Health Questionnaire 4 score below 3 * No functional impairment
Where this trial is running
New York, New York
- New School — New York, New York, United States (Recruiting)
Study contacts
- Principal investigator: Brandon Kohrt, MD, PhD — George Washington University
- Study coordinator: Adam Brown, PhD
- Email: brownad@newschool.edu
- Phone: 212-229-5727
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.